# Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease

> **NCT04143841** · NA · TERMINATED · sponsor: **Epitech Mag Ltd.** · enrollment: 50 (actual)

## Conditions studied

- Dry Eye Syndromes
- ATD
- Sjogren's Syndrome

## Interventions

- **DEVICE:** Viveye OMNS treatment
- **DEVICE:** Viveye OMNS sham treatment

## Key facts

- **NCT ID:** NCT04143841
- **Lead sponsor:** Epitech Mag Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-30
- **Primary completion:** 2021-01-06
- **Final completion:** 2021-01-06
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Financial constraints
- **Last updated:** 2021-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04143841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04143841, "Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT04143841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*